Lourdes Ibáñez Selected Research

Flutamide (Eulexin)

6/2015	Metabolomics reveals impaired maturation of HDL particles in adolescents with hyperinsulinaemic androgen excess.
12/2010	Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
8/2010	Therapy: Low-dose flutamide for hirsutism: into the limelight, at last.
5/2007	Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
7/2006	Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
5/2006	Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
2/2006	Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
9/2005	High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
7/2005	Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women.
1/2005	Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lourdes Ibáñez Research Topics

Disease

37	Insulin Resistance 07/2022 - 06/2002
21	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 05/2020 - 02/2002
18	Hyperandrogenism 07/2010 - 06/2002
15	Birth Weight (Birth Weights) 01/2017 - 05/2002
12	Obesity 01/2021 - 07/2005
12	Hirsutism 10/2017 - 06/2002
7	Hyperinsulinism (Hyperinsulinemia) 01/2019 - 06/2002
7	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019 - 10/2007
5	Body Weight (Weight, Body) 07/2022 - 06/2003
5	Inflammation (Inflammations) 01/2019 - 04/2004
5	Acne Vulgaris 01/2017 - 07/2003
4	Oligomenorrhea 05/2020 - 06/2003
4	Dyslipidemias (Dyslipidemia) 01/2004 - 06/2002
3	Weight Gain 01/2022 - 06/2004
3	Overweight 01/2021 - 10/2009
3	Infertility (Sterility) 10/2017 - 05/2013
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2014 - 12/2003
3	Hypoadiponectinemia 07/2012 - 09/2004
2	Gestational Weight Gain 01/2018 - 11/2015
2	Pre-Eclampsia (Preeclampsia) 01/2017 - 12/2012
2	Menstruation Disturbances 01/2017 - 01/2014
2	Maternal Obesity 01/2017 - 11/2015
2	Metabolic Diseases (Metabolic Disease) 11/2015 - 09/2007
2	Hypertriglyceridemia 06/2015 - 04/2004
2	Type 2 Diabetes Mellitus (MODY) 06/2015 - 11/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2014 - 02/2006
2	Anovulation 12/2002 - 06/2002
1	Abdominal Obesity 05/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2020
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2017
1	Hypertension (High Blood Pressure) 04/2016
1	Pediatric Obesity 03/2016
1	Glucose Intolerance 06/2015
1	Hyperglycemia 06/2015

Drug/Important Bio-Agent (IBA)

36	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 06/2002
24	AndrogensIBA 05/2020 - 05/2002
22	Insulin (Novolin)FDA Link 01/2020 - 06/2002
17	Flutamide (Eulexin)FDA LinkGeneric 06/2015 - 06/2002
14	LipidsIBA 01/2021 - 06/2003
10	AdiponectinIBA 01/2022 - 04/2004
10	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2003
7	C-Reactive ProteinIBA 01/2022 - 02/2006
6	Triglycerides (Triacylglycerol)IBA 01/2022 - 06/2002
5	Oral ContraceptivesIBA 01/2021 - 01/2003
5	Pioglitazone (Actos)FDA Link 01/2021 - 12/2010
5	HDL CholesterolIBA 01/2020 - 06/2002
5	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017 - 01/2004
5	drospirenone FDA LinkGeneric 02/2006 - 04/2004
4	Contraceptive Agents (Contraceptives)IBA 01/2021 - 09/2004
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 11/2011
4	Sex Hormone-Binding GlobulinIBA 01/2018 - 12/2002
4	Testosterone (Sustanon)FDA Link 05/2013 - 06/2002
3	Spironolactone (Aldactone)FDA LinkGeneric 01/2021 - 01/2018
3	C-PeptideIBA 04/2016 - 09/2013
3	Alanine Transaminase (SGPT)IBA 06/2014 - 07/2005
3	AdipokinesIBA 06/2014 - 04/2004
3	LeptinIBA 10/2012 - 06/2006
3	Androgen Receptors (Androgen Receptor)IBA 12/2010 - 07/2003
3	Dehydroepiandrosterone SulfateIBA 10/2009 - 06/2002
2	CholesterolIBA 01/2022 - 12/2003
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2016
2	HDL LipoproteinsIBA 01/2020 - 09/2007
2	Hormones (Hormone)IBA 01/2017 - 06/2007
2	MicroRNAs (MicroRNA)IBA 01/2017 - 11/2015
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2015 - 12/2011
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 06/2014 - 05/2007
2	OsteocalcinIBA 03/2014 - 07/2008
2	Mitochondrial DNA (mtDNA)IBA 01/2014 - 02/2006
2	Progestins (Progestagens)IBA 01/2014 - 12/2010
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 07/2012 - 01/2005
2	Growth Hormone (Somatotropin)IBA 01/2012 - 01/2005
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2012 - 06/2004
2	Plasminogen Activators (Plasminogen Activator)IBA 10/2007 - 02/2002
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2007 - 07/2005
2	Interleukin-6 (Interleukin 6)IBA 06/2005 - 04/2004
2	Androstenedione (4 Androstene 3,17 dione)IBA 06/2004 - 06/2002
2	Progesterone FDA LinkGeneric 07/2002 - 06/2002
1	SecretagoguesIBA 07/2022
1	Peptide Hormones (Polypeptide Hormones)IBA 07/2022
1	FructosamineIBA 01/2022
1	5-methoxy-methylindoleacetic acid (DBI)IBA 11/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	ChemokinesIBA 01/2020
1	Phosphorus (Red Phosphorus)IBA 12/2018
1	CalciumIBA 12/2018
1	alpha-2-HS-GlycoproteinIBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 04/2016
1	EnzymesIBA 04/2016
1	CatecholaminesIBA 03/2016
1	WD repeat containing planar cell polarity effectorIBA 06/2014
1	Superoxide DismutaseIBA 01/2014
1	GonadotropinsIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2014

Therapy/Procedure

18	Therapeutics 01/2012 - 06/2002
4	Contraception (Birth Control) 01/2018 - 10/2003
1	Diet Therapy (Therapy, Diet) 04/2020